Tredje AP fonden lessened its holdings in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 1.6% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,338 shares of the aerospace company’s stock after selling 321 shares during the quarter. Tredje AP fonden’s holdings in Leidos were worth $2,967,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently bought and sold shares of LDOS. Boston Partners raised its position in shares of Leidos by 5.8% during the 1st quarter. Boston Partners now owns 3,430,264 shares of the aerospace company’s stock worth $449,592,000 after acquiring an additional 188,458 shares in the last quarter. Norges Bank acquired a new stake in Leidos during the fourth quarter worth approximately $202,191,000. Northern Trust Corp lifted its position in shares of Leidos by 0.5% during the 4th quarter. Northern Trust Corp now owns 1,149,948 shares of the aerospace company’s stock worth $124,470,000 after buying an additional 6,284 shares during the last quarter. Panagora Asset Management Inc. boosted its holdings in shares of Leidos by 39.7% in the 2nd quarter. Panagora Asset Management Inc. now owns 782,161 shares of the aerospace company’s stock valued at $114,102,000 after buying an additional 222,179 shares in the last quarter. Finally, Balyasny Asset Management L.P. grew its position in shares of Leidos by 9,164.4% in the 4th quarter. Balyasny Asset Management L.P. now owns 578,561 shares of the aerospace company’s stock valued at $62,623,000 after buying an additional 572,316 shares during the last quarter. 76.12% of the stock is currently owned by institutional investors and hedge funds.
Leidos Trading Up 1.5 %
NYSE LDOS opened at $156.09 on Friday. Leidos Holdings, Inc. has a 52-week low of $89.22 and a 52-week high of $159.10. The firm has a 50-day moving average price of $151.11 and a 200 day moving average price of $142.71. The stock has a market capitalization of $21.03 billion, a P/E ratio of 67.28, a P/E/G ratio of 1.38 and a beta of 0.70. The company has a quick ratio of 1.11, a current ratio of 1.21 and a debt-to-equity ratio of 0.91.
Leidos Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, September 27th. Shareholders of record on Friday, September 13th will be given a dividend of $0.38 per share. The ex-dividend date is Friday, September 13th. This represents a $1.52 annualized dividend and a dividend yield of 0.97%. Leidos’s payout ratio is currently 65.52%.
Insider Transactions at Leidos
In other news, Director Gary Stephen May sold 1,000 shares of the stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total value of $144,020.00. Following the completion of the transaction, the director now owns 11,264 shares in the company, valued at approximately $1,622,241.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Thomas Arthur Bell purchased 1,712 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was acquired at an average price of $145.04 per share, for a total transaction of $248,308.48. Following the completion of the transaction, the chief executive officer now directly owns 22,398 shares in the company, valued at approximately $3,248,605.92. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Gary Stephen May sold 1,000 shares of Leidos stock in a transaction on Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total value of $144,020.00. Following the transaction, the director now directly owns 11,264 shares of the company’s stock, valued at approximately $1,622,241.28. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on LDOS. Royal Bank of Canada upped their price objective on shares of Leidos from $140.00 to $145.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 31st. Barclays raised their price target on Leidos from $160.00 to $165.00 and gave the stock an “overweight” rating in a research note on Monday, August 5th. Wells Fargo & Company boosted their price objective on Leidos from $168.00 to $172.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Stifel Nicolaus raised their target price on shares of Leidos from $160.00 to $165.00 and gave the stock a “buy” rating in a research report on Monday, June 24th. Finally, JPMorgan Chase & Co. upped their price target on shares of Leidos from $165.00 to $175.00 and gave the company an “overweight” rating in a research report on Wednesday, July 31st. Two equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $163.08.
Get Our Latest Analysis on Leidos
Leidos Profile
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Stories
- Five stocks we like better than Leidos
- How is Compound Interest Calculated?
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- How to Use Stock Screeners to Find Stocks
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- What Does a Stock Split Mean?
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.